Evercyte GmbH
Corporate brand
UnclaimedAustrian life-science company providing telomerized human cell models and extracellular vesicle production platforms for preclinical research.
Last updated September 26, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Evercyte GmbH is an Austrian biotechnology company that supplies specialized human cell models and extracellular vesicle (EV) production systems for preclinical research and development. According to its official website, the company's purpose is the "establishment of cell cultures for preclinical testings and scalable EV production." Evercyte utilizes human primary-like cell models to develop in vitro test systems that enable the standardization of preclinical models and advanced platforms such as organ-on-a-chip systems. Its cells also serve as cell factories for the production of targeting extracellular vesicles for clinical applications. The company's core technology is the circumvention of replicative senescence by ectopic expression of hTERT (human telomerase reverse transcriptase). Normal human cells can undergo only a limited number of population doublings before entering replicative senescence, an irreversible growth arrest that restricts their utility in biotechnological applications. Evercyte introduces hTERT expression to extend the proliferative capacity of these cells while preserving cell type-specific characteristics. Evercyte focuses on the isolation of mesenchymal stromal cells from different tissues and the establishment of production systems for extracellular vesicles and recombinant vesicles. It also aims to set up preclinical test systems that represent the human body and allow toxicity studies or the evaluation of the potency of compounds or exosomes. The company offers a range of products through its online shop, including telomerized cells derived from various tissues such as adipose tissue, bone marrow, colon, cornea, dental pulp, endometrium, kidney, lung, mammary gland, muscle, placenta, skin, thymus, vascular system, umbilical cord, and urine. It also provides an EV toolbox and related services and resources. Evercyte is headquartered in Vienna, Austria, and operates as a private company. It serves the biotechnology and biomedical research markets, providing tools for drug discovery, toxicity testing, and EV-based therapeutic development.
History
Evercyte GmbH is an Austrian biotechnology company headquartered in Vienna. The company was founded to commercialize technology for extending the proliferative capacity of human cells, specifically through the ectopic expression of hTERT (human telomerase reverse transcriptase). This approach allows normal human cells to bypass replicative senescence while maintaining their cell type-specific characteristics, making them valuable tools for biotechnology and biomedical research. Evercyte's core focus has been on the isolation of mesenchymal stromal cells (MSCs) from various human tissues and the establishment of production systems for extracellular vesicles (EVs) and recombinant vesicles. The company provides specialized human primary-like cell models for the development of in vitro test systems that enable the standardization of preclinical models and advanced platforms such as organ-on-a-chip systems. These cells also serve as cell factories for the production of targeting extracellular vesicles for clinical applications. The company offers a catalog of telomerized cells derived from a wide range of tissues, including adipose tissue, bone marrow, colon, cornea, dental pulp, endometrium, kidney, lung, mammary gland, muscle, placenta, skin, thymus, vascular system, umbilical cord, and urine. Notable products include ASC/TERT1 and ASC/TERT300 adipose-derived mesenchymal stromal cells, and BM-MSC/TERT292 bone-marrow-derived mesenchymal stromal cells. Evercyte also provides an EV toolbox and related services and resources through its website. As of the latest available information, Evercyte continues to operate as a private company, serving the biotechnology and biomedical research markets with its cell models and EV production platforms.
Products and positioning
Provider of standardized human cell models and scalable EV production platforms for preclinical research and drug development.
ASC/TERT1
Adipose-derived mesenchymal stromal cells
ASC/TERT300
Adipose-derived mesenchymal stromal cells – EV cell factory
BM-MSC/TERT292
Bone-marrow-derived mesenchymal stromal cells
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/evercyte-gmbh · Editorial policy · How profiles are compiled